Field notes
What we've learned navigating denials.
Tactics, denial-code playbooks, and the patterns we see across 50+ carriers. Honest, specific, no fluff.
Industry
Apr 28, 2026 · 6 min
Why fewer than 1% of denied claims are ever appealed
The system runs on the bet that you'll give up. Here's how that bet got built — and why it works on almost everyone.
Read post
Drug coverage
Apr 21, 2026 · 7 min
GLP-1 denials (Wegovy, Ozempic, Zepbound): what actually flips them
BMI thresholds, T2D pathways, formulary exceptions. The three angles that win most GLP-1 appeals — and the one that wins them faster.
Read post
Medicare
Apr 14, 2026 · 8 min
Medicare Advantage has five appeal levels. Most people stop at one.
Level 1 reverses 41%. Level 2 (Maximus) reverses higher. Level 3 (ALJ) is where the real wins happen. Here's the full ladder.
Read post
How to
Apr 7, 2026 · 5 min
What a winning appeal letter actually contains
Appeals aren't pleas. They're rebuttals. Five things every winning letter has — and the one phrase that does most of the work.
Read post
Prior auth
Mar 31, 2026 · 5 min
Prior authorization: the denial that isn't really a denial
Most 'denials' are actually prior-auth refusals — and there's a separate, faster path to reverse them. Most patients don't know it exists.
Read post